Kees Fluiter

Assistant professor

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kees Fluiter is an Assistant Professor at Leiden University Medical Center (LUMC) in the Netherlands. His research focuses on neuroinflammation, complement systems, and their roles in neurological diseases, as evidenced by his recent articles exploring lipid homeostasis in Schwann cells and the effects of complement inhibition in various neurological models. Dr. Fluiter is actively involved in investigating therapeutic interventions aimed at mitigating secondary injuries following traumatic brain injury.

Articles (8)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Paul Morgan

Professor of Immunology

Cardiff University

UNITED KINGDOM

View details

Frédéric A Meunier

AUSTRALIA

View details

Frank Baas

Professor of Genome Diagnostics

Leiden University

NETHERLANDS

View details

Lars Verschuren

TNO

NETHERLANDS

View details

Esther Wolfs

Assistant professor

UHasselt

BELGIUM

View details

Gregers Rom Andersen

Aarhus University

DENMARK

View details

Cees van Kooten

Professor Experimental Nephrology & Transplant Immunology

LUMC

NETHERLANDS

View details

Ivo Lambrichts

Prof.dr.

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kees Fluiter

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells.

Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody

The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed PMP22

Editorial: Complement in nervous system disease.

Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice.

Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex

Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury

Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial.

Collaborators (8)

Paul Morgan

Frédéric A Meunier

Frank Baas

Lars Verschuren

Esther Wolfs

Gregers Rom Andersen

Cees van Kooten

Ivo Lambrichts

Make your next move.